| 1 |
Trouseau A. Phlegmasia Alba Dolens: Clinique Medicale de lʼHotel-Dieu de Paris [J]. New Sydenham Soc, 1865, 2: 695-727.
|
| 2 |
Khorana AA. Venous thromboembolism and prognosis in cancer [J]. Thromb Res, 2010, 125(6): 490-493.
|
| 3 |
Sack GH, Levin J, Bell WR. Trousseauʼs syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features [J]. Medicine, 1977, 56(1): 1-37.
|
| 4 |
Navi BB, Reiner AS, Kamel H, et al. Risk of arterial thromboembolism in patients with cancer [J]. J Am Coll Cardiol, 2017, 70(8): 926-938.
|
| 5 |
Zhen C, Wang Y, Wang H, et al. Multiple cerebral infarction linked to underlying cancer: a review of Trousseau syndrome-related cerebral infarction [J]. Br J Hosp Med (Lond), 2021, 82(5): 1-7.
|
| 6 |
Kim K, Lee JH. Risk factors and biomarkers of ischemic stroke in cancer patients [J]. J Stroke, 2014, 16(2): 91.
|
| 7 |
Kono T, Ohtsuki T, Hosomi N, et al. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer: cancer-associated ischemic stroke [J]. Geriatr Gerontol Int, 2012, 12(3): 468-474.
|
| 8 |
Finelli PF, Nouh A. Three-territory DWI acute infarcts: diagnostic value in cancer-associated hypercoagulation stroke (Trousseau syndrome) [J]. Am J Neuroradiol, 2016, 37(11): 2033-2036.
|
| 9 |
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke, 2019, 50(12): e344-e418.
|
| 10 |
Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke [J]. Eur Stroke J, 2021, 6(1): Ⅰ-LⅫ.
|
| 11 |
Mosconi MG, Capponi A, Pierini P, et al. Safety and efficacy of intravenous thrombolysis in patients with acute stroke and active cancer: retrospective cohort study [J]. Neurol Sci, 2022, 43(6): 4003-4006.
|
| 12 |
Oki S, Kawabori M, Echizenya S, et al. Long-term clinical outcome and prognosis after thrombectomy in patients with concomitant malignancy [J]. Front Neurol, 2020, 11: 572589.
|
| 13 |
Sallustio F, Mascolo AP, Marrama F, et al. Safety and Efficacy of Reperfusion Therapies for Acute Ischemic Stroke Patients with Active Malignancy [J]. J Stroke Cerebrovasc Dis, 2019, 28(8): 2287-2291.
|
| 14 |
Vedovati MC, Germini F, Agnelli G, et al. Direct oral anticoagulants in patients with VTE and cancer [J]. Chest, 2015, 147(2): 475-483.
|
| 15 |
Yoo J, Nam HS, Kim YD, et al. Short-term outcome of ischemic stroke patients with systemic malignancy [J]. Stroke, 2019, 50(2): 507-511.
|
| 16 |
Lee JH, Yoon SH, Hong H, et al. Incidence, risk factors, and prognostic indicators of symptomatic air embolism after percutaneous transthoracic lung biopsy: a systematic review and pooled analysis [J]. Eur Radiol, 2021, 31(4): 2022-2033.
|
| 17 |
Dearborn JL, Urrutia VC, Zeiler SR. Stroke and cancer-a complicated relationship [J]. J Neurol Transl Neurosci, 2014, 2(1): 1039.
|
| 18 |
Ganguly K, Rauth S, Marimuthu S, et al. Unraveling mucin domains in cancer and metastasis: when protectors become predators [J]. Cancer Metastasis Rev, 2020, 39(3): 647-659.
|
| 19 |
Patil S, Darcourt J, Messina P, et al. Characterising acute ischaemic stroke thrombi: insights from histology, imaging and emerging impedance-based technologies [J]. Stroke Vasc Neurol, 2022, 7(4): 353-363.
|